Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03112694 · ClinicalTrials.gov registry record
Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors
A clinical trial, sponsored by Ipsen.
- Completed
- Registry status
- 93
- Enrollment target
NCT03112694 is a clinical trial that has completed, run by Ipsen. The registered enrollment target is 93 participants.
The verdict
NCT03112694 has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- 93 participants
- Enrollment target
Study Summary
The purpose of this study is to understand how people with neuroendocrine tumors respond to treatment with lanreotide after having received treatment with octreotide.
Interventions
- OTHER Data collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2017-04-04 |
| Est. Completion | 2017-11-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03112694
The ClinicalTrials.gov registry entry for NCT03112694 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Data collection is the first listed.
NCT03112694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03112694 about?
NCT03112694 is a clinical study titled "Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors". The purpose of this study is to understand how people with neuroendocrine tumors respond to treatment with lanreotide after having received treatment with octreotide.
What is the current status of trial NCT03112694?
This trial is currently completed. The enrollment target is 93 participants. The study started on 2017-04-04. Estimated completion is 2017-11-02.
What interventions are being tested in trial NCT03112694?
The interventions under investigation include: Data collection (OTHER).
Who is sponsoring clinical trial NCT03112694?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.